Flipping the Script on the Podcast: Host Andy Dean on Anxiety Disorders Treatment

In this episode, Dr. Susan Murray tackles some of the most persistent misconceptions about eating disorders head-on – and then we get into GLP-1 medications and what the rise in use means for this patient population. It's an honest, nuanced conversation about where the field is, where it's going, and what clinicians and patients need to know right now.

Anorexia nervosa isn't just a behavioral issue – it's a neurobiological one. In this episode, Dr. Susan Murray breaks down the neuroscience behind anorexia, why targeting the brain's role in the disorder leads to better treatment outcomes, and how Penn Medicine Princeton Center for Eating Disorders integrates neurobiological approaches into its eating disorder care. If you want to understand why eating disorders are so difficult to treat – and how we’re addressing that – this is the episode for you.

In this episode, Dr. Susan Murray dives deep into the program philosophy driving care at Penn Medicine Princeton Center for Eating Disorders. We cover the treatment modalities they use, why giving patients autonomy over their own meal choices matters, and how exposure-based work fits into a comprehensive eating disorder treatment plan. It’s a must-listen for anyone involved in or curious about the recovery process.

What does it take to build a great eating disorder treatment program? In this episode, Dr. Susan Murray walks us through her clinical background, the philosophy behind effective curriculum design, and the treatment modalities that drive real outcomes at Penn Medicine Princeton Center for Eating Disorders for both inpatient treatment and intensive outpatient programs. Whether you're a clinician, a patient, or a family member trying to understand the landscape of eating disorder care, thispodcast is packed with insight.

As GLP-1 medications like Ozempic and Wegovy reshape conversations about weight and body image, what does this mean for those with eating disorders? Dr. Becca Boswell, PhD, tackles this timely topic head-on, discussing the treatment implications of GLP-1s for this population. She also explores how eating disorders present differently across genders and why a one-size-fits-all approach to treatment often falls short.